Neuroone Medical Technologies Corp reports results for the quarter ended in June - Earnings Summary

Neuroone Medical Technologies

11/08/2022 22:03

* Neuroone Medical Technologies Corp  NMTC.OQ  reported a
quarterly adjusted loss of 17 cents​​ per share for the quarter
ended in June. The mean expectation of two analysts for the
quarter was for a loss of 22 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Neuroone Medical Technologies Corp's reported EPS for the
quarter was a loss of 17 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Neuroone Medical Technologies Corp shares had risen
by 135.7%
this quarter and lost 0.3% so far this year.
    * The company reported a quarterly loss of $2.76 million.
    * Wall Street's median 12-month price target for Neuroone
Medical
Technologies Corp is $2.63 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 09:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.22          -0.17          Beat
 Mar. 31 2022      -0.20          -0.19          Beat
 Dec. 31 2021      -0.18          -0.18          Met
 Sep. 30 2021      -0.22          -0.22          Met